News

Healing Realty Trust Appoints Richard Gatward to Advisory Board

Jupiter, Florida--(Newsfile Corp. - November 4, 2024) - Healing Realty Trust ("HRT" or the "Company"), a data-driven, self-managed real estate…

1 year ago

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the…

1 year ago

Abstract Describing Significant Results of Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Accepted for Presentation at San Antonio Breast Cancer Symposium (SABCS)

Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of…

1 year ago

Catheter Precision, Inc. Announces New Clinical Data Presented at SCRN

FORT MILL, SC / ACCESSWIRE / November 4, 2024 / Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device…

1 year ago

CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer

Experienced CFO and investment banker with 30-year track record will help drive CureVac's transformationTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE…

1 year ago

CureVac to Present at the 12th International mRNA Health Conference

TÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / November 4, 2024 / CureVac N.V. (Nasdaq:CVAC) ("CureVac"), a global biopharmaceutical company…

1 year ago

NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement

ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ("NLS"), a biopharmaceutical…

1 year ago

Philips enrolls first patient in U.S. clinical trial for innovative integrated single-device to treat peripheral artery disease

THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device,…

1 year ago

Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing

SALT LAKE CITY, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and…

1 year ago

Renovaro Issues Shareholder Letter and Provides Corporate Update

LOS ANGELES, Nov. 04, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered…

1 year ago